Ozenoxacin 245765-41-7 99%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:1MT
- Time:2024-01-16
Product Details
- Product NameOzenoxacin
- CAS No.245765-41-7
- EINECS No.105-745-2
- MFC21H21N3O3
- MW363.41
- AppearanceSolidOff-White
- Boiling point 573.5±50.0 °C(Predicted)
- density 1.372±0.06 g/cm3(Predicted)
- storage temp. 2-8°C(protect from light)
- Melting point >255°C (dec.)
Company Profile Introduction
The PRECISE Group established in 1997, with an annual turnover of 40 million USD is among the respected pharmaceutical companies in India. With a Well-trained regulatory team, dedicated F&D unit and 100+ professionals Precise Group has been established as a one-stop solution for API, Intermediates and Finished Formulations. With our core strengths, we are making our base stronger in the global market.
?
The Precise group started with Bulk Drug manufacturing and then diversified into Drug Pellets and Formulations to provide our customers with end-to-end solutions to their various pharmaceutical product needs. The Group is slowly making its presence felt in the competitive healthcare market with its fair business practices, consistent customer services and quality of medical products. It is poised to become a leading Pharmaceutical Manufacturer in India and Internationally. The Group now exports to almost 30 countries and it is also an approved API supplier to manufacturers like ABBOTT, SUN PHARMA, TEVA, RANBAXY, Dr. REDDY’s, PLIVA and several other key pharma players in the markets around the world.
Supplier other products
Recommended supplier
-
VIP1年
- Maithri Drugs Pvt Ltd
- 245765-41-7 Ozenoxacin 98%
- Inquiry
- 2024-03-28
-
VIP1年
- Metrochem API Private Limited
- Ozenoxacin 98%
- Inquiry
- 2024-01-03
-
VIP1年
- Sekhment pharmaventures
- Ozenoxacin 99%
- Inquiry
- 2024-01-02
-
VIP1年
- Sekhment pharmaventures
- Ozenoxacin 99%
- Inquiry
- 2024-01-02
- Since:2020-01-01
- Address: E311 & E312, 3RD FLOOR, EASTERN BUSINESS DISTRICT, NEPTUNE MALL, NEAR MANGATRAM PETROL PUMP,LBS MARG
INQUIRY